UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | W | X | Y | Z
Number of items: 166.

A

Abraham, DJ; Krieg, T; Distler, J; Distler, O; (2009) Overview of pathogenesis of systemic sclerosis. RHEUMATOLOGY , 48 3 - 7. 10.1093/rheumatology/ken481.

Aden, N; Nuttall, A; Xu, SW; Denton, C; Black, C; Abraham, D; Stratton, R; (2009) IgG autoantibodies from scleroderma patients induces interleukin-1 alpha secretion. CLIN EXP RHEUMATOL , 27 (3) S81 - S81.

Aden, NH; Nuttall, A; Xu, SW; Denton, C; Black, C; Abraham, D; Stratton, R; (2009) STRESS SIGNAL TRANSDUCTION PATHWAYS ACTIVATED IN EPIDERMAL KERATINOCYTES IN SYSTEMIC SCLEROSIS. In: RHEUMATOLOGY. (pp. I27 - I27). OXFORD UNIV PRESS

Amorosi, S; Russo, I; Amodio, G; Garbi, C; Vitiello, L; Palamaro, L; Adriani, M; ... Pignata, C; + view all (2009) The Cellular Amount of the Common gamma-Chain Influences Spontaneous or Induced Cell Proliferation. JOURNAL OF IMMUNOLOGY , 182 (5) pp. 3304-3309. 10.4049/jimmunol.0802400.

Aslam, R; Howat, S; Xu, S; Abraham, D; Baker, D; (2009) Vascular Basement Membrane Changes in Human Critical Limb Ischemia Are a Consequence of Upregulated Matrix Metalloproteinase and Tissue Inhibitor of Matrix Metalloproteinase Activity. In: (Proceedings) 10th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. (pp. E92-E93). LIPPINCOTT WILLIAMS & WILKINS

Aslam, R; Khan, K; Shiwen, X; Abraham, DJ; Black, CM; Baker, DM; (2009) The Interplay of Matrix Metaloproteinases and tissue inhibitors of matrix metaloproteinases may account for basement membrane changes in critical limb ischaemia. In: (pp. p. 69).

B

Beirne, P; Pantelidis, P; Charles, P; Wells, AU; Abraham, DJ; Denton, CP; Welsh, KI; ... Kelleher, P; + view all (2009) Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. EUR RESPIR J , 34 (6) 1376 - 1382. 10.1183/09031936.00028209.

Blair, PA; Chavez-Rueda, KA; Evans, JG; Shlomchik, MJ; Eddaoudi, A; Isenberg, DA; Ehrenstein, MR; (2009) Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice. J IMMUNOL , 182 (6) 3492 - 3502. 10.4049/jimmunol.0803052.

Bowyer, A; Mikolajek, H; Stuart, JW; Wood, SP; Jamil, F; Rashid, N; Akhtar, M; (2009) Structure and function of the L-threonine dehydrogenase (TkTDH) from the hyperthermophilic archaeon Thermococcus kodakaraensis. J STRUCT BIOL , 168 (2) 294 - 304. 10.1016/j.jsb.2009.07.011.

Bridoux, F; Jaccard, A; Sirac, C; Gillmore, JD; Cogne, M; Grateau, G; Touchard, G; (2009) Atteintes uro-néphrologiques au cours des maladies systémiques. In: Bagnis, CI and Cacoub, P and Deray, G, (eds.) Atteintes uro-néphrologiques au cours des maladies systémiques.

C

Cai, C-L; Martin, JC; Sun, Y; Cui, L; Wang, L; Ouyang, K; Yang, L; ... Evans, SM; + view all (2009) Tbx18 and the fate of epicardial progenitors Cai et al. reply. NATURE , 458 (7240) E9-E10. 10.1038/nature07917.

Chambers, SA; Allen, E; Rahman, A; Isenberg, D; (2009) Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. RHEUMATOLOGY , 48 (6) pp. 673-675. 10.1093/rheumatology/kep062.

Chambers, SA; Raine, R; Rahman, A; Isenberg, D; (2009) Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications A qualitative study in a UK cohort. RHEUMATOLOGY , 48 (3) 266 - 271. 10.1093/rheumatology/ken479.

Chavele, KM; Martinez-Pomares, L; Gordon, S; Cook, T; Pusey, C; Salama, A; (2009) Circulating mannose receptor is elevated in acute ANCA-associated vasculitis and contributes in the development of experimental glomerulonephritis. APMIS , 117 154 - 154.

Chen, YL; Leask, A; Abraham, DJ; Kennedy, L; Xu, SW; Denton, CP; Black, CM; (2009) Thrombospondin 1 is a key mediator of TGF beta-mediated cell contractility in systemic sclerosis via a MEK/ERK-dependent mechanism. CLIN EXP RHEUMATOL , 27 (3) S83 - S83.

Choi, D; Radziszewska, A; Schroer, SA; Liadis, N; Liu, YF; Zhang, Y; Lam, PPL; ... Woo, M; + view all (2009) Deletion of Fas in the pancreatic beta-cells leads to enhanced insulin secretion. AM J PHYSIOL-ENDOC M , 297 (6) E1304 - E1312. 10.1152/ajpendo.00217.2009.

Ciurtin, C; Cojocaru, M; (2009) First analysis of complex metabolic composition of synovial fluid in scleroderma by proton magnetic resonance spectroscopy. In: (pp. S77-S78). CLINICAL & EXPER RHEUMATOLOGY

Ciurtin, C; Dabu, M; Dabu, B; Stoica, V; (2009) Is leptin a marker for arthritis in hypothyroidism? In: (pp. p. 743). CLINICAL & EXPER RHEUMATOLOGY

Clarkin, CE; Cheung, I; Hughes, CE; Poulet, B; Edwards, JCW; (2009) Phenotypic plasticity of superficial zone chondrocytes is revealed by increased glycosaminoglycan release and a unique angiogenic secretory profile from neo-cartilage grafts. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY , 90 (2) A103-A104.

Cojocaru, M; Ciurtin, C; (2009) Two dimensional tear protein electrophoresis for differential diagnosis of ocular manifestation in scleroderma. In: (pp. S78-S78). CLINICAL & EXPER RHEUMATOLOGY

Corato, M; Ogliari, P; Ceciliani, F; Cova, E; Bellotti, V; Cereda, C; Merlini, G; (2009) Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster. Anticancer Research: international journal of cancer research and treatment , 29 pp. 2507-2512.

Cresswell, L; Yee, C-S; Farewell, V; Rahman, A; Teh, L-S; Griffiths, B; Bruce, IN; ... Gordon, C; + view all (2009) Numerical scoring for the Classic BILAG index. RHEUMATOLOGY , 48 (12) pp. 1548-1552. 10.1093/rheumatology/kep183.

D

Danesh, J; Pepys, MB; (2009) C-Reactive Protein and Coronary Disease Is There a Causal Link? CIRCULATION , 120 (21) 2036 - 2039. 10.1161/CIRCULATIONAHA.109.907212.

Dashwood, MR; Savage, K; Tsui, JCS; Dooley, A; Shaw, SG; Alfonso, MSF; Bodin, L; (2009) Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. J THORAC CARDIOV SUR , 138 (2) 334 - 340. 10.1016/j.jtcvs.2008.11.060.

De Vallière, S; Mary, C; Joneberg, JE; Rotman, S; Bullani, R; Greub, G; Gillmore, JD; ... Tarr, PE; + view all (2009) Case report: AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient. American Journal of Tropical Medicine and Hygiene , 81 (2) pp. 209-212.

Denton, CP; Derrett-Smith, EC; (2009) Juvenile-onset systemic sclerosis: children are not small adults. RHEUMATOLOGY , 48 (2) 96 - 97. 10.1093/rheumatology/ken418.

Denton, CP; Engelhart, M; Tvede, N; Wilson, H; Khan, K; Shiwen, X; Carreira, PE; ... van den Hoogen, FH; + view all (2009) An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis. ANNALS OF THE RHEUMATIC DISEASES , 68 (9) pp. 1433-1439. 10.1136/ard.2008.096123.

Denton, CP; Khan, K; Hoyles, RK; Xu, S; Leoni, P; Chen, Y; Eastwood, M; (2009) Inducible Lineage-Specific Deletion of T beta RII in Fibroblasts Defines a Pivotal Regulatory Role during Adult Skin Wound Healing. JOURNAL OF INVESTIGATIVE DERMATOLOGY , 129 (1) pp. 194-204. 10.1038/jid.2008.171.

Denton, CP; Lapadula, G; Mouthon, L; Mueller-Ladner, U; (2009) Renal complications and scleroderma renal crisis. RHEUMATOLOGY , 48 pp. 32-35. 10.1093/rheumatology/ken483.

Derrett-Smith, EC; Denton, CP; Sonnylal, S; (2009) Animal models of scleroderma: lessons from transgenic and knockout mice. CURR OPIN RHEUMATOL , 21 (6) 630 - 635. 10.1097/BOR.0b013e32833130c1.

Derrett-Smith, EC; Dooley, A; Khan, K; Shi-Wen, X; Abraham, D; Denton, CP; (2009) Aortic Smooth Muscle Cells Show a Pro-Fibrotic Phenotype in a TGF-Beta Dependant Mouse Model of Systemic Sclerosis. Arthritis and Rheumatism , 60 (S10) p. 1061.

Derrett-Smith, EC; Dooley, A; Khan, K; Xu, SW; De Winter, P; Abraham, D; Denton, CP; (2009) VASCULOPATHY IN A TGF-beta DEPENDENT MOUSE MODEL OF SYSTEMIC SCLEROSIS. In: RHEUMATOLOGY. (pp. I11 - I11). OXFORD UNIV PRESS

Derrett-Smith, EC; Khan, K; Xu, SW; De Winter, P; Abraham, D; Denton, CP; (2009) Pulmonary and systemic vasculopathy in a TGF-beta dependent mouse model of systemic sclerosis. CLIN EXP RHEUMATOL , 27 (3) S82 - S82.

Disterer, P; Simons, JP; Owen, JS; (2009) Validation of oligonucleotide-mediated gene editing. GENE THER , 16 (6) 824 - 826. 10.1038/gt.2009.32.

Dooley, A; Low, SY; Harrison, E; Holmes, A; Kidane, AG; Abraham, DJ; Black, CM; (2009) Nitric oxide metabolism and antioxidant expression in the tight skin mouse model of fibrosis. CLIN EXP RHEUMATOL , 27 (3) S85 - S85.

Dooley, A; Xu, SW; Aden, N; Tranah, T; Desai, N; Denton, CP; Black, CM; ... Bruckdorfer, R; + view all (2009) MODULATION OF TYPE I COLLAGEN SYNTHESIS AND FIBROBLAST FUNCTION IN SYSTEMIC SCLEROSIS BY THE GREEN TEA ANTIOXIDANT (-)-EPIGALLOCATECHIN-3-GALLATE. In: RHEUMATOLOGY. (pp. I78 - I79). OXFORD UNIV PRESS

de Cruz, M; Pawarova, B; Lachmann, H; Gillmore, J; Gibbs, S; Sattianayagam, P; Hawkins, P; (2009) Early Detection of Cardiac Systolic Functional Impairment and Correlation with NT-ProBNP Change in AL Amyloidosis by Cardiac Lateral Wall Tissue Doppler S Wave. In: BLOOD. (pp. 1100 - 1100). AMER SOC HEMATOLOGY

de Vallière, S; Mary, C; Joneberg, JE; Rotman, S; Bullani, R; Greub, G; Gillmore, JD; ... Tarr, PE; + view all (2009) AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient. Am J Trop Med Hyg , 81 (2) pp. 209-212.

F

Fonseca, C; Abraham, D; Ponticos, M; (2009) Neuronal Regulators and Vascular Dysfunction in Raynaud's Phenomenon and Systemic Sclerosis. CURR VASC PHARMACOL , 7 (1) 34 - 39.

Ford, C; Coltart, C; Williams, D; Giles, I; (2009) SYSTEMATIC REVIEW AND META-ANALYSIS OF PREGNANCY OUTCOMES IN LUPUS NEPHRITIS. In: RHEUMATOLOGY. (pp. I45 - I45). OXFORD UNIV PRESS

G

Gibbs, SD; Sattianayagam, PT; Wechalekar, AD; Lachmann, HJ; Hawkins, PN; Gillmore, JD; (2009) Solid Organ Transplantation in AL Amyloidosis: Lessons Learned and Its Current Role. CLIN LYMPHOMA MYELOM , 9 S71 - S71.

Gibbs, SDJ; De Cruz, M; Sattianayagam, PT; Lachmann, HJ; Gillmore, JD; Hawkins, PN; Wechalekar, AD; (2009) Transient Post Chemotherapy Rise in NT Pro-BNP in AL Amyloidosis : Implications for Organ Response Assessment. In: BLOOD. (pp. 712 - 712). AMER SOC HEMATOLOGY

Gibbs, SDJ; Gillmore, JD; Sattianayagam, PT; Offer, M; Lachmann, HJ; Hawkins, PN; Wechalekar, AD; (2009) In AL Amyloidosis, Both Oral Melphalan and Dexamethasone (Mel-Dex) and Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Have Similar Efficacy as Upfront Treatment. In: BLOOD. (pp. 310 - 310). AMER SOC HEMATOLOGY

Gibbs, SDJ; Sattianayagam, PT; Gillmore, JD; Offer, M; Lachmann, HJ; Hawkins, PN; Wechalekar, AD; (2009) Is There a Role for Thalidomide Maintenance in the Treatment of AL Amyloidosis? In: BLOOD. (pp. 739 - 739). AMER SOC HEMATOLOGY

Gibbs, SDJ; Sattianayagam, PT; Hawkins, PN; Gillmore, JD; (2009) Cardiac transplantation should be considered in selected patients with either AL or hereditary forms of amyloidosis: the UK National Amyloidosis Centre experience. INTERN MED J , 39 (11) 786 - 787. 10.1111/j.1445-5994.2009.02017.x.

Giles, I; Perieleous, C; Liu, XW; Ehsanullah, J; Clarke, L; Brogan, P; Newton-West, M; ... Rahman, A; + view all (2009) Thrombin Binding Predicts the Effects of Sequence Changes in a Human Monoclonal Antiphospholipid Antibody on Its In Vivo Biologic Actions. J IMMUNOL , 182 (8) 4836 - 4843. 10.4049/jimmunol.0804241.

Giles, I; Rahman, A; (2009) How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , 23 (4) pp. 525-537. 10.1016/j.berh.2009.01.009.

Gill, R; Kolstoe, SE; Mohammed, F; Al D-Bass, A; Mosely, JE; Sarwar, M; Cooper, JB; ... Shoolingin-Jordan, PM; + view all (2009) Structure of human porphobilinogen deaminase at 2.8 angstrom: the molecular basis of acute intermittent porphyria. BIOCHEM J , 420 17 - 25. 10.1042/BJ20082077.

Gillmore, J; Cocks, K; Gibbs, SDJ; Sattianayagam, PT; Lane, T; Lachmann, H; Schey, S; ... Wechalekar, AD; + view all (2009) Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Versus Melphalan Plus Dexamethasone (MD) for Newly-Diagnosed Systemic AL Amyloidosis - Results From the UK Amyloidosis Treatment Trial. In: BLOOD. (pp. 1120 - 1120). AMER SOC HEMATOLOGY

Gillmore, JD; Lachmann, HJ; Rowczenio, D; Gilbertson, JA; Zeng, CH; Liu, ZH; Li, LS; ... Hawkins, PN; + view all (2009) Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen A alpha-Chain Amyloidosis. J AM SOC NEPHROL , 20 (2) 444 - 451. 10.1681/ASN.2008060614. Gold open access

Giorgetti, S; Raimondi, S; Cassinelli, S; Bucciantini, M; Stefani, M; Gregorini, G; Albonico, G; ... Bellotti, V; + view all (2009) beta2-Microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. Nephrol Dial Transplant , 24 (4) pp. 1176-1181. 10.1093/ndt/gfn623.

Goldblatt, F; Chambers, S; Rahman, A; Isenberg, DA; (2009) Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. LUPUS , 18 (8) 682 - 689. 10.1177/0961203308101019.

Goldblatt, F; Yuste, J; Isenberg, DA; Rahman, A; Brown, J; (2009) Impaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus. RHEUMATOLOGY , 48 (12) 1498 - 1501. 10.1093/rheumatology/kep289.

H

Hague, S; Heetun, M; Farooqui, N; Loizidou, M; Dashwood, M; Shiwen, X; Abraham, D; (2009) Efficacy of the specific ETA receptor antagonist zibotentan (ZD4054) in cancer cells and fibroblasts from colorectal cancer. In: AMER ASSOC CANCER RESEARCH

Harding, SJ; Margetts, C; Bradwell, AR; Mead, G; Hawkins, PN; Lachmann, H; (2009) Hevylite (TM) Detects Residual IgG kappa in IgG Heavy-chain Disease. In: (pp. S100-S101). CIG MEDIA GROUP, LP

Hazenberg, AJC; Dikkers, FG; Hawkins, PN; Bijzet, J; Rowczenio, D; Gilbertson, J; Posthumus, MD; ... Hazenberg, BPC; + view all (2009) Laryngeal Presentation of Systemic Apolipoprotein A-I-Derived Amyloidosis. LARYNGOSCOPE , 119 (3) pp. 608-615. 10.1002/lary.20106.

Herrick, AL; Lunt, M; Whidby, N; Ennis, H; Silman, A; McHugh, N; Denton, CP; (2009) OBSERVATIONAL STUDY OF TREATMENT OUTCOME IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS. In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I26-I26). OXFORD UNIV PRESS

Herrick, AL; Roberts, C; Tracey, A; Silman, A; Anderson, M; Goodfield, M; McHugh, N; ... Denton, CP; + view all (2009) Lack of Agreement Between Rheumatologists in Defining Digital Ulceration in Systemic Sclerosis. ARTHRITIS AND RHEUMATISM , 60 (3) pp. 878-882. 10.1002/art.24333.

Howell, KJ; Lavorato, A; Visentin, MT; Smith, RE; Schaefer, G; Jones, CD; Weibel, L; ... Woo, P; + view all (2009) Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised scleroderma. SKIN RESEARCH AND TECHNOLOGY , 15 (3) pp. 346-356. 10.1111/j.1600-0846.2009.00371.x.

Howell, KJ; Lavorato, A; Visentin, MT; Smith, RE; Schaefer, G; Jones, CD; Weibel, L; ... Woo, P; + view all (2009) Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised scleroderma. Skin Res Technol , 15 (3) pp. 346-356. 10.1111/j.1600-0846.2009.00371.x.

I

Ikeda, T; Lindahl, G; Fragiadaki, M; Shi-Wen, X; Ponticos, M; Garcia, P; Denton, C; ... Abraham, D; + view all (2009) FUNCTIONAL REGULATION OF FIBROSIS BY CUTL1 ISOFORMS. In: RHEUMATOLOGY. (pp. I74 - I75). OXFORD UNIV PRESS

Ioannou, Y; Giles, IP; (2009) New therapies for the management of the antiphospholipid syndrome. Current Medical Literature (28) pp. 81-89.

Ioannou, Y; Romay-Penabad, Z; Pericleous, C; Giles, I; Papalardo, E; Vargas, G; Shilagard, T; ... Pierangeli, S; + view all (2009) In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta(2)-glycoprotein I: proof of concept. J THROMB HAEMOST , 7 (5) 833 - 842. 10.1111/j.1538-7836.2009.03316.x.

Ito, K; Sawamura, D; Goto, M; Nakamura, H; Nishie, W; Sakai, K; Natsuga, K; ... Shimizu, H; + view all (2009) Keratinocyte-/Fibroblast-Targeted Rescue of Col7a1-Disrupted Mice and Generation of an Exact Dystrophic Epidermolysis Bullosa Model Using a Human COL7A1 Mutation. AM J PATHOL , 175 (6) 2508 - 2517. 10.2353/ajpath.2009.090347.

K

Kamesh, L; Heward, JM; Williams, JM; Gough, SCL; Chavele, KM; Salama, A; Pusey, C; ... Harper, L; + view all (2009) CT60 and+49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. RHEUMATOLOGY , 48 (12) 1502 - 1505. 10.1093/rheumatology/kep280.

Kapoor, M; McCann, M; Liu, SX; Huh, K; Denton, CP; Abraham, DJ; Leask, A; (2009) Loss of Peroxisome Proliferator-Activated Receptor gamma in Mouse Fibroblasts Results in Increased Susceptibility to Bleomycin-Induced Skin Fibrosis. ARTHRITIS RHEUM , 60 (9) 2822 - 2829. 10.1002/art.24761.

Kapoor, M; Shi-Wen, X; Denton, CP; Abraham, DJ; Leask, A; (2009) PPAR-GAMMA AGONIST ROSIGLITAZONE ALLEVIATES THE FIBROTIC PHENOTYPE OF SKIN SCLERODERMA FIBROBLASTS. WOUND REPAIR REGEN , 17 (4) A70 - A70.

Khan, K; Hoyles, R; Xu, S; Abraham, D; Denton, CP; (2009) DISRUPTION OF TGFBETA SIGNALLING IN DERMAL FIBROBLASTS DELAYS SKIN WOUND HEALING AND REDUCES FIBROCYTE RECRUITMENT. In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I79-I79). OXFORD UNIV PRESS

Kidane, AG; Burriesci, G; Cornejo, P; Dooley, A; Sarkar, S; Bonhoeffer, P; Edirisinghe, M; (2009) Current Developments and Future Prospects for Heart Valve Replacement Therapy. J BIOMED MATER RES B , 88B (1) 290 - 303. 10.1002/jbm.b.31151.

Kimura, A; Stevenson, PL; Carter, RN; MacColl, G; French, KL; Simons, JP; Al-Shawi, R; ... Holmes, MC; + view all (2009) Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity. EUR J NEUROSCI , 30 (2) 299 - 306. 10.1111/j.1460-9568.2009.06831.x.

Kitley, J; Ginsberg, L; Pinto, A; Lachmann, H; (2009) THE NEUROLOGICAL MANIFESTATIONS OF THE CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. ? - ?). B M J PUBLISHING GROUP

Kolstoe, SE; Ridha, BH; Bellotti, V; Wang, N; Robinson, CV; Crutch, SJ; Keir, G; ... Pepys, MB; + view all (2009) Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component. P NATL ACAD SCI USA , 106 (18) 7619 - 7623. 10.1073/pnas.0902640106.

Kowal-Bielecka, O; Landewe, R; Avouac, J; Chwiesko, S; Miniati, I; Czirjak, L; Clements, P; ... Matucci-Cerinic, M; + view all (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). ANNALS OF THE RHEUMATIC DISEASES , 68 (5) pp. 620-628. 10.1136/ard.2008.096677.

Kuemmerle-Deschner, J; Lachmann, HJ; Kone-Paut, I; Leslie, K; Hachulla, E; Quartier, P; Krammer, G; ... Hawkins, PN; + view all (2009) One-year results of canakinumab (ACZ885), a fully human anti-IL-1beta monoclonal antibody in patients with cryopyrin-associated periodic fever syndrome (CAPS). SWISS MED WKLY , 139 (31-32) 4S - 4S. Gold open access

L

Lachmann, H; Kone-Paut, I; Kuemmerle-Deschner, J; Leslie, K; Hachulla, E; Quartier, P; Gitton, X; ... Hawkins, PN; + view all (2009) EFFICACY AND SAFETY OF CANAKINUMAB (ACZ885), A FULLY HUMAN ANTI-INTERLEUKIN-1BETA ANTIBODY, IN CRYOPYRIN-ASSOCIATED PERIODIC FEVER SYNDROME: RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY. In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I34-I35). OXFORD UNIV PRESS

Lachmann, H; Lowe, P; Offer, M; Rordorf, C; Gitton, X; Patel, NP; Hawkins, PN; (2009) TREATMENT OF CRYOPYRIN ASSOCIATED PERIODIC FEVER SYNDROME WITH A LONG-ACTING FULLY HUMAN ANTI-IL-1BETA MONOCLONAL ANTIBODY (ACZ885). In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I115-I115). OXFORD UNIV PRESS

Lachmann, HJ; Hawkins, PN; (2009) Developments in the scientific and clinical understanding of autoinflammatory disorders. ARTHRITIS RES THER , 11 (1) , Article 212. 10.1186/ar2579. Gold open access

Lachmann, HJ; Kone-Paut, I; Kuemmerle-Deschner, JB; Leslie, KS; Hachulla, E; Quartier, P; Gitton, X; ... Canakinumab CAPS Study Grp, ; + view all (2009) Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome. NEW ENGL J MED , 360 (23) 2416 - 2425.

Lachmann, HJ; Lowe, P; Felix, SD; Rordorf, C; Leslie, K; Madhoo, S; Wittkowski, H; ... Jung, T; + view all (2009) In vivo regulation of interleukin 1 beta in patients with cryopyrin-associated periodic syndromes. J EXP MED , 206 (5) 1029 - 1036. 10.1084/jem.20082481.

Lambrianides, A; Pierangeli, S; Latchman, D; Isenberg, D; Rahman, A; Giles, I; (2009) STATINS AND HYDROXYCHLOROQUINE CAN PREVENT THE PROCOAGULANT/THROMBOGENIC PROPERTIES OF ANTIPHOSPHOLIPID ANTIBODIES IN MONOCYTES. In: RHEUMATOLOGY. (pp. I48 - I48). OXFORD UNIV PRESS

Leask, A; Parapuram, SK; Xu, S-W; Abraham, DJ; (2009) Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? JOURNAL OF CELL COMMUNICATION AND SIGNALING , 3 (2) pp. 89-94. 10.1007/s12079-009-0037-7.

Lewis, MJ; Malik, TH; Ehrenstein, MR; Boyle, JJ; Botto, M; Haskard, DO; (2009) Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. CIRCULATION , 120 (5) 417 - U101. 10.1161/CIRCULATIONAHA.109.868158.

Lindahl, G; Leoni, P; Ponticos, M; Xu, SW; Renzoni, E; Holmes, A; Black, CM; ... Abraham, DJ; + view all (2009) CONSTITUTIVE NUCLEAR ACCUMULATION OF CBF IN SYSTEMIC SCLEROSIS PULMONARY FIBROBLASTS: A PUTATIVE TRANSCRIPTIONAL MECHANISM UNDERLYING THE FIBROTIC PHENOTYPE. In: RHEUMATOLOGY. (pp. I77 - I77). OXFORD UNIV PRESS

Liu, S; Kapoor, M; Denton, CP; Abraham, DJ; Leask, A; (2009) LOSS OF INTEGRIN 1 RESULTS IN RESISTANCE TO BLEOMYCIN-INDUCED SCLERODERMA. WOUND REPAIR REGEN , 17 (4) A72 - A72.

Liu, SX; Kapoor, M; Denton, CP; Abraham, DJ; Leask, A; (2009) Loss of beta 1 Integrin in Mouse Fibroblasts Results in Resistance to Skin Scleroderma in a Mouse Model. ARTHRITIS RHEUM , 60 (9) 2817 - 2821. 10.1002/art.24801.

Liu, SX; Kapoor, M; Xu, SW; Kennedy, L; Denton, CP; Abraham, DJ; Leask, A; (2009) Investigation of the role of Racl in a bleomycin-induced scleroderma model using fibroblast-specific Racl knockout mice. CLIN EXP RHEUMATOL , 27 (3) S72 - S72.

Loesch, A; Dashwood, MR; (2009) On the sympathetic innervation of the human greater saphenous vein: relevance to clinical practice. Curr Vasc Pharmacol , 7 (1) pp. 58-67.

Lu, TY-T; Ng, KP; Cambridge, G; Leandro, MJ; Edwards, JCW; Ehrenstein, M; Isenberg, DA; (2009) A Retrospective Seven-Year Analysis of the Use of B Cell Depletion Therapy in Systemic Lupus Erythematosus at University College London Hospital: The First Fifty Patients. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH , 61 (4) pp. 482-487. 10.1002/art.24341.

Lyengar, S; Ayto, R; Wechalekar, A; Dwanga, F; Mehta, AB; Hughes, DA; (2009) A clinical audit of venous thromboprophylaxis in multiple myeloma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 12 - 12). WILEY-BLACKWELL PUBLISHING, INC

M

Manson, JJ; Jury, E; Mills, K; Isenberg, DA; Rahman, A; (2009) THE PODOCYTE IN LUPUS NEPHRITIS: HOW DO PATHOGENIC AUTOANTIBODIES EXERT THEIR EFFECT? RHEUMATOLOGY , 48 I47 - I47.

Manson, JJ; Ma, A; Rogers, P; Mason, LJ; Berden, JH; van der Vlag, J; D'Cruz, DP; ... Rahman, A; + view all (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. ARTHRITIS RES THER , 11 (5) , Article R154. 10.1186/ar2831.

Maskrey, BH; Bermúdez-Fajardo, A; Morgan, AH; Stewart-Jones, E; Dioszeghy, V; Taylor, GW; Baker, PRS; ... O apos Donnell, VB; + view all (2009) Erratum: Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase (Journal of Biological Chemistry (2007) vol. 282 (20151-20163)). Journal of Biological Chemistry , 284 (37) 25460-. 10.1074/jbc.A611776200.

Matucci-Cerinic, M; Guillevin, L; Denton, CP; Schwierin, B; Rosenberg, D; Silkey, M; Krieg, T; (2009) Demographics and previous complications/interventions in patients with digital ulcers and different subsets of scleroderma: preliminary findings front the DUO registry. In: (pp. p. 713). CLINICAL & EXPER RHEUMATOLOGY

Mauri, C; Carter, N; (2009) Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs. ARTHRITIS RES THER , 11 (4) , Article 237. 10.1186/ar2752.

Mead, GP; Stubbs, PD; Goodman, HJB; Hawkins, PN; (2009) Serum and Urine Light Chains in AL Amyloidosis. In: (pp. S106-S106). CIG MEDIA GROUP, LP

Montagna, G; Raimondi, S; Moro, G; Uggetti, C; Relini, A; Magrini, U; Esposito, G; ... Bellotti, V; + view all (2009) Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. Amyloid , 16 (3) pp. 115-121. 10.1080/13506120903090783.

Moser, C; Pohl, G; Haslinger, I; Knapp, S; Rowczenio, D; Russel, T; Lachmann, HJ; ... Kovarik, J; + view all (2009) Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. NEPHROL DIAL TRANSPL , 24 (2) 676 - 678. 10.1093/ndt/gfn646.

Mulla, M; Brosens, J; Chamley, LW; Giles, I; Pericleous, C; Rahman, A; Joyce, SK; ... Abrahams, VM; + view all (2009) Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. American Journal of Reproductive Immunology , 62 pp. 96-111.

Mulla, MJ; Brosens, JJ; Chamley, LW; Giles, I; Pericleous, C; Rahman, A; Joyce, SK; ... Abrahams, VM; + view all (2009) Antiphospholipid Antibodies Induce a Pro-Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway. AM J REPROD IMMUNOL , 62 (2) 96 - 111. 10.1111/j.1600-0897.2009.00717.x.

N

Narshi, CB; Haider, S; Ford, CM; Isenberg, DA; Giles, IP; (2009) RITUXIMAB AS PRIMARY THERAPY FOR PULMONARY HAEMORRHAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS. In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I21-I21). OXFORD UNIV PRESS

Nihtyanova, S; Wierk, A; Denton, CP; (2009) Characteristics of juvenile onset systemic sclerosis patients in an adult single centre cohort Does this patient population present a survival bias? In: (pp. S73-S73). CLINICAL & EXPER RHEUMATOLOGY

Nihtyanova, SI; Parker, JC; Black, CM; Bunn, CC; Denton, CP; (2009) DOES ANTI-RNA-POLYMERASE ANTIBODY LEVEL PREDICT ORGAN INVOLVEMENT OR DISEASE OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS? In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I76-I76). OXFORD UNIV PRESS

Nihtyanova, SI; Parker, JC; Black, CM; Bunn, CC; Denton, CP; (2009) A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis. RHEUMATOLOGY , 48 (10) pp. 1218-1221. 10.1093/rheumatology/kep215.

O

O'Donnell, VB; Maskrey, B; Taylor, GW; (2009) Eicosanoids: generation and detection in mammalian cells. Methods Mol Biol , 462 pp. 5-23.

O'Neill, SG; Pego-Reigosa, JM; Hingorani, AD; Bessant, R; Isenberg, DA; Rahman, A; (2009) Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus. RHEUMATOLOGY , 48 (5) 573 - 575. 10.1093/rheumatology/kep037.

O'Neill, SG; Woldman, S; Bailliard, F; Norman, W; McEwan, J; Isenberg, DA; Taylor, AM; (2009) Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. ANN RHEUM DIS , 68 (9) 1478 - 1481. 10.1136/ard.2008.098053.

Obici, L; Raimondi, S; Lavatelli, F; Bellotti, V; Merlini, G; (2009) Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum , 61 (10) pp. 1435-1440. 10.1002/art.24735.

Ong, V.H.; (2009) Expression and regulation of monocyte chemoattractant protein-3 (MCP-3) in fibrosis. Doctoral thesis , UCL (University College London). Green open access
file

Ong, VH; Carulli, MT; Xu, S; Khan, K; Lindahl, G; Abraham, DJ; Denton, CP; (2009) Cross-talk between MCP-3 and TGF beta promotes fibroblast collagen biosynthesis. EXPERIMENTAL CELL RESEARCH , 315 (2) pp. 151-161. 10.1016/j.yexcr.2008.11.001.

Osman, E; Evans, V; Graham, IR; Athanasopoulos, T; McIntosh, J; Nathwani, AC; Simons, JP; ... Owen, JS; + view all (2009) Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice. ATHEROSCLEROSIS , 204 (1) 121 - 126. 10.1016/j.atherosclerosis.2008.08.043.

P

Pakozdi, A; Nihtyanova, SI; Brough, GM; Black, CM; Denton, CP; (2009) CLINICAL AND SEROLOGICAL HALLMARKS OF SYSTEMIC SCLEROSIS OVERLAP SYNDROMES. In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I26-I26). OXFORD UNIV PRESS

Pakozdi, A; Wilson, H; Black, CM; Denton, CP; (2009) Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis? Clin Exp Rheumatol , 27 (3 Suppl ) pp. 5-8.

Pakozdi, A; Wilson, H; Black, CM; Denton, CP; (2009) Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , 27 (3) S5-S8.

Penn, H; Tennant-Eyles, AJ; Howat, SL; Stratton, RJ; Coglan, JG; Pearson, JD; Denton, CP; (2009) Anti-endothelial cell antibody levels are low in scleroderma internal organ vasculopathies. In: (pp. S84-S84). CLINICAL & EXPER RHEUMATOLOGY

Pepys, MB; (2009) The Allergy Archives: Pioneers and Milestones. Jack Pepys (May 15, 1914 - September 9, 1996): a personal recollection. J Allergy Clin Immunol , 123 (3) pp. 718-720.

Pepys, MB; (2009) A molecular correlate of clinicopathology in transthyretin amyloidosis. J PATHOL , 217 (1) 1 - 3. 10.1002/path.2467.

Pericleous, C; Giles, I; Rahman, A; (2009) Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? LUPUS , 18 (8) 671 - 675. 10.1177/0961203309103062.

Pericleous, C; Rahman, A; Giles, I; (2009) Do antiphospholipid antibodies have direct pathologic effects upon endometrial and trophoblast cells? Current Rheumatology Reviews , 5 (2) pp. 83-97. 10.2174/157339709788298455.

Pericleous, C; Rahman, A; Giles, I; (2009) Do antiphospholipid antibodies have direct pathologic effects upon endometrial and trophoblast cells? Current Rheumatology Reviews , 5 pp. 83-97.

Pimenta, D; Haque, S; Heetun, M; Dashwood, M; Shiwen, W; Farooqui, N; Abraham, D; (2009) The Endothelin Axis in Drug Sensitive and Multidrug Resistant Bladder Cancer Cells. In: (pp. p. 27).

Ponticos, M; Harvey, C; Ikeda, T; Abraham, D; Bou-Gharios, G; (2009) JunB mediates enhancer/promoter activity of COL1A2 following TGF-beta induction. NUCLEIC ACIDS RES , 37 (16) 5378 - 5389. 10.1093/nar/gkp544. Gold open access

Ponticos, M; Harvey, C; Ikeda, T; Abraham, D; Bou-Gharios, G; (2009) JunB mediates enhancer/promoter activity of COL1A2 following TGF-beta induction. Nucleic Acids Res. , 37 (16) pp. 5378-5389.

Ponticos, M; Holmes, AM; Shi-wen, X; Leoni, P; Khan, K; Rajkumar, V; Hoyles, R; ... Lindahl, G; + view all (2009) Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. , 60 (7) pp. 2142-2155.

Ponticos, M; Holmes, AM; Xu, SW; Leoni, P; Khan, K; Rajkumar, VS; Hoyles, RK; ... Lindahl, GE; + view all (2009) Pivotal Role of Connective Tissue Growth Factor in Lung Fibrosis MAPK-Dependent Transcriptional Activation of Type I Collagen. ARTHRITIS RHEUM , 60 (7) 2142 - 2155. 10.1002/art.24620.

Porticos, M; Holmes, A; Xu, S-W; Hoyles, R; Bou-Gharios, G; Black, CM; Denton, CP; ... Lindahl, GE; + view all (2009) CTGF Contributes to collagen type I expression in the bleomycin model of lung fibrosis and in human pulmonary fibroblasts by MAPK dependent transcriptional activation. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , 27 (3) S84-S84.

Q

Quillinan, NP; Denton, CP; (2009) Disease-modifying treatment in systemic sclerosis: current status. CURRENT OPINION IN RHEUMATOLOGY , 21 (6) pp. 636-641. 10.1097/BOR.0b013e3283310d57.

R

Radziszewska, A; Choi, D; Nguyen, KTT; Schroer, SA; Tajmir, P; Wang, L; Suzuki, A; ... Woo, M; + view all (2009) PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic beta Cells. J BIOL CHEM , 284 (5) 2917 - 2922. 10.1074/jbc.M805183200. Gold open access

Radziszewska, A; Schroer, SA; Choi, D; Tajmir, P; Radulovich, N; Ho, JC; Wang, LY; ... Woo, M; + view all (2009) Absence of Caspase-3 Protects Pancreatic beta-Cells from c-Myc-induced Apoptosis without Leading to Tumor Formation. J BIOL CHEM , 284 (16) 10947 - 10956. 10.1074/jbc.M806960200. Gold open access

Rennella, E; Corazza, A; Fogolari, F; Viglino, P; Giorgetti, S; Stoppini, M; Bellotti, V; (2009) Equilibrium unfolding thermodynamics of beta2-microglobulin analyzed through native-state H/D exchange. Biophys J , 96 (1) pp. 169-179. 10.1529/biophysj.108.142448.

Ricagno, S; Raimondi, S; Giorgetti, S; Bellotti, V; Bolognesi, M; (2009) Human beta-2 microglobulin W60V mutant structure: Implications for stability and amyloid aggregation. Biochem Biophys Res Commun , 380 (3) pp. 543-547. 10.1016/j.bbrc.2009.01.116.

S

Sattianayagam, P; Gibbs, S; Hawkins, P; Gillmore, J; (2009) Systemic AL (light-chain) amyloidosis and the gastrointestinal tract. SCAND J GASTROENTERO , 44 (11) 1384 - 1385. 10.3109/00365520903254296.

Sattianayagam, P; Gibbs, SD; Wechalekar, A; Gilbertson, JA; Lachmann, HJ; Philip, HN; Gillmore, JD; (2009) Systemic AA Amyloidosis in Crohn's Disease (CD): A Serum Amyloid P Component (SAP) Scintigraphy Study. In: GASTROENTEROLOGY. (pp. A188 - A188). W B SAUNDERS CO-ELSEVIER INC

Sattianayagam, P; Gibbs, SDJ; Waterworth, C; De Cruz, M; Pawarova, B; Rowcenzio, D; Lachmann, HJ; ... Gillmore, JD; + view all (2009) Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy secondary to variant transthyretin (Ala60). In: (pp. p. 869). OXFORD UNIV PRESS

Sattianayagam, PT; Gibbs, SDJ; Gilbertson, J; Hawkins, PN; Gillmore, JD; (2009) Diagnosing amyloid with a rectal biopsy-how important is it? J GASTROEN HEPATOL , 24 A258 - A258.

Sattianayagam, PT; Gibbs, SDJ; Gilbertson, J; Hawkins, PN; Lachmann, HJ; (2009) Amyloid in a liver biopsy-what does it indicate? J GASTROEN HEPATOL , 24 A276 - A276.

Sattianayagam, PT; Gibbs, SDJ; Wechalekar, AD; Lachmann, HJ; Hawkins, PN; Gillmore, JD; (2009) Outcomes of Heart Transplantation for Cardiac Amyloidosis: Subanalysis of the Spanish Registry for Heart Transplantation. AM J TRANSPLANT , 9 (10) 2443 - 2443. 10.1111/j.1600-6143.2009.02790.x.

Sattianayagam, PT; Gibbs, SDJ; Wechalekar, AD; Lachmann, HJ; Hawkins, PN; Gillmore, JD; (2009) Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the Spanish registry for heart transplantation. Am J Transplant , 9 (10) 2443-. 10.1111/j.1600-6143.2009.02790.x.

Sattianayagam, PT; Hawkins, PN; Gillmore, JD; (2009) Amyloid and the GI tract. Expert Rev Gastroenterol Hepatol , 3 (6) pp. 615-630.

Sattianayagam, PT; Hawkins, PN; Gillmore, JD; (2009) Systemic amyloidosis and the gastrointestinal tract. NAT REV GASTRO HEPAT , 6 (10) 608 - 617. 10.1038/nrgastro.2009.147.

Shi-wen, X; Liu, S; Eastwood, M; Sonnylal, S; Denton, CP; Abraham, DJ; Leask, A; (2009) Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts. PLoS ONE , 4 (10) 10.1371/journal.pone.0007438.

Shi-wen, X; Liu, SX; Eastwood, M; Sonnylal, S; Denton, CP; Abraham, DJ; Leask, A; (2009) Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts. PLOS ONE , 4 (10) , Article e7438. 10.1371/journal.pone.0007438. Green open access
file

Shi-wen, X; Parapuram, S; Pala, D; Chen, Y; Carter, DE; Eastwood, M; Denton, C; ... Leask, A; + view all (2009) TGF beta-induced a-smooth muscle actin expression and extracellular matrix contraction in fibroblasts requires TAK1. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , 27 (3) S82-S82.

Shi-wen, X; Parapuram, SK; Pala, D; Chen, YL; Carter, DE; Eastwood, M; Denton, CP; ... Leask, A; + view all (2009) Requirement of Transforming Growth Factor beta-Activated Kinase 1 for Transforming Growth Factor beta-Induced alpha-Smooth Muscle Actin Expression and Extracellular Matrix Contraction in Fibroblasts. ARTHRITIS RHEUM , 60 (1) 234 - 241. 10.1002/art.24223.

Shiwen, X; Leask, A; Abraham, DJ; Fonseca, C; (2009) Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma. EUR J CLIN INVEST , 39 19 - 26. 10.1111/j.1365-2362.2009.02117.x.

Shiwen, X; Leask, A; Abraham, DJ; Fonseca, C; (2009) Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma. European journal of clinical investigation , 39 Sup pp. 19-26. 10.1111/j.1365-2362.2009.02117.x.

Simonneau, G; Robbins, IM; Beghetti, M; Channick, RN; Delcroix, M; Denton, CP; Elliott, CG; ... Souza, R; + view all (2009) Updated Clinical Classification of Pulmonary Hypertension. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , 54 (1) S43-S54. 10.1016/j.jacc.2009.04.012.

Simons, JP; Al-Shawi, R; Minogue, S; Waugh, MG; Wiedemann, C; Evangelou, S; Loesch, A; ... Hsuan, JJ; + view all (2009) Loss of phosphatidylinositol 4-kinase 2 alpha activity causes late onset degeneration of spinal cord axons. P NATL ACAD SCI USA , 106 (28) 11535 - 11539. 10.1073/pnas.0903011106. Gold open access

Sonnylal, S; Garcis, P; Bou-Gharios, G; Abraham, D; de Crombrugghe, B; (2009) Fibroblast-directed CTGF over-expression in vivo promotes systemic connective tissue fibrosis reminiscent of fibroproliferative diseases. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , 27 (3) S79-S79.

Steen, V; Denton, CP; Pope, JE; Matucci-Cerinic, M; (2009) Digital ulcers: overt vascular disease in systemic sclerosis. In: RHEUMATOLOGY. (pp. 19 - 24). OXFORD UNIV PRESS

Stefan, LI; Nicolescu, A; Popa, SG; Ciurtin, C; Mota, M; Deleanu, C; Kovacs, E; (2009) THE STUDY OF URINARY METABOLITES EXCRETION IN HEALTHY INDIVIDUALS AND TYPE I DIABETES MELLITUS PATIENTS USING NMR SPECTROSCOPY. In: (Proceedings) Annual Meeting of the American-Association-for-Clinical-Chemistry. (pp. A210-A210). AMER ASSOC CLINICAL CHEMISTRY

Stoppini, M; Obici, L; Lavatelli, F; Giorgetti, S; Marchese, L; Moratti, R; Bellotti, V; (2009) Proteomics in protein misfolding diseases. Clin Chem Lab Med , 47 (6) pp. 627-635. 10.1515/CCLM.2009.164.

T

Tang, EC; Nihtyanova, SI; Denton, CP; (2009) CONTEMPORARY OUTCOME IN SYSTEMIC SCLEROSIS: IMPROVED SURVIVAL WITH EARLIER RECOGNITION OF ORGAN-BASED COMPLICATIONS. In: (Proceedings) Annual Meeting of the British-Society-of-Rheumatology. (pp. I78-I78). OXFORD UNIV PRESS

Thoua, NM; Forbes, A; Denton, CP; Emmanuel, AV; (2009) Faecal Incontinence in Systemic Sclerosis Is Related to Neuropathy. In: (Proceedings) Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association. (pp. A219-A219). W B SAUNDERS CO-ELSEVIER INC

W

Walker, UA; Tyndall, A; Czirjak, L; Denton, CP; Farge-Bancel, D; Kowal-Bielecka, O; Mueller-Ladner, U; (2009) Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. ANNALS OF THE RHEUMATIC DISEASES , 68 (6) pp. 856-862. 10.1136/ard.2008.091348.

Wechalekar, A; Hawkins, PN; Wassef, NJ; Gillmore, ND; Lachmann, HJ; Morris, J; Thomas, M; ... Mead, G; + view all (2009) Monoclonal Protein Detection in AL Amyloidosis Revisited: Analysis of 642 Patients. CLIN LYMPHOMA MYELOM , 9 S49 - S49.

Wechalekar, A; Merlini, G; Gillmore, JD; Russo, P; Lachmann, HJ; Obici, L; Hawkins, PN; (2009) A New Method of Response Assessment in AL Amyloidosis Using NT-ProBNP with Hematologic Response. CLIN LYMPHOMA MYELOM , 9 S51 - S51.

Wechalekar, AD; Offer, M; Gillmore, JD; Hawkins, PN; Lachmann, HJ; (2009) Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutation. NAT CLIN PRACT CARD , 6 (2) 128 - 133. 10.1038/ncpcardio1423.

Wechalekar, AD; Wassef, N; Lachmann, H; Sattianayagam, P; Gibbs, SDJ; Gillmore, J; Hawkins, PN; (2009) HIGH EARLY MORTALITY AND POOR OUTCOMES FOR PATIENTS WITH AL AMYLOIDOSIS PRESENTING WITH HIGH SERUM FREE LIGHT CHAINS - A NEW RISK STRATIFICATION MODEL. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 222 - 222). FERRATA STORTI FOUNDATION Gold open access

Wechalekar, AD; Wassef, NL; Gibbs, SDJ; Gillmore, J; Dike, F; Lachmann, H; Sattianayagam, P; ... Hawkins, PN; + view all (2009) A New Staging System for AL Amyloidosis Incorporating Serum Free Light Chains, cardiac Troponin-T and NT-ProBNP. In: BLOOD. (pp. 1093 - 1094). AMER SOC HEMATOLOGY

Woodhoo, A; Alonso, MBD; Droggiti, A; Turmaine, M; D'Antonio, M; Parkinson, DB; Wilton, DK; ... Jessen, KR; + view all (2009) Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. NAT NEUROSCI , 12 (7) 839 - U46. 10.1038/nn.2323. Gold open access

Wright, GP; Notley, CA; Xue, SA; Bendle, GM; Holler, A; Schumacher, TN; Ehrenstein, MR; (2009) Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. P NATL ACAD SCI USA , 106 (45) 19078 - 19083. 10.1073/pnas.0907396106.

X

Xu, S; Parapuram, S; Pala, D; Carter, D; Eastwood, M; Denton, C; Black, C; ... Abraham, D; + view all (2009) TGF-BETA INDUCTION OF THE MYOFIBROBLAST PHENOTYPE REQUIRES TAK-1. RHEUMATOLOGY , 48 I77-I77.

Xu, S; Rajkumar, V; Denton, CP; Leask, A; Abraham, DJ; (2009) Pericytes display increased CCN2 expression upon culturing. JOURNAL OF CELL COMMUNICATION AND SIGNALING , 3 (1) pp. 61-64. 10.1007/s12079-009-0053-7.

Xu, SW; Pala, D; Chen, YL; Eastwood, M; Denton, CP; Abraham, DJ; Leask, A; (2009) TGF beta-INDUCED alpha-SMOOTH MUSCLE ACTIN EXPRESSION AND EXTRACELLULAR MATRIX CONTRACTION IN FIBROBLASTS REQUIRES TAK1. WOUND REPAIR REGEN , 17 (4) A79 - A79.

Y

Yee, C-S; Farewell, V; Isenberg, DA; Griffiths, B; Teh, L-S; Bruce, IN; Ahmad, Y; ... Gordon, C; + view all (2009) The BILAG-2004 index is sensitive to change for assessment of SLE disease activity. RHEUMATOLOGY , 48 (6) pp. 691-695. 10.1093/rheumatology/kep064.

Z

Zweers, MC; Schmitz, M; Peters, A; Denton, CP; Fassler, R; Gullberg, D; Krieg, T; (2009) Dermal reconstitution following injury requires integrin-linked kinase. CLIN EXP RHEUMATOL , 27 (3) S76 - S76.

This list was generated on Sun Dec 10 03:02:42 2017 GMT.